News & Updates
Filter by Specialty:

Aspirin cuts HCC risk in CHB patients with heavy metabolic burden
22 Nov 2021
byTristan Manalac
Aspirin safely lowers the risk of hepatocellular carcinoma (HCC) among chronic hepatitis B (CHB) patients suffering from a heavy burden of metabolic risk, according to a study presented at The Liver Meeting Digital Experience 2021 of the American Association for the Study of Liver Diseases (AASLD 2021).
Aspirin cuts HCC risk in CHB patients with heavy metabolic burden
22 Nov 2021
Daratumumab-containing regimens safe, effective against multiple myeloma
21 Nov 2021
Adding daratumumab to backbone treatments against multiple myeloma (MM) yields high clinical efficacy and has an acceptable toxicity profile, a recent study has found. Such regimens are good treatment options for newly diagnosed (ND) and relapsed/refractory (RR) MM.